TALIDAT Kaupastillen against heartburn, 50 pcs

Instructions for use for TALIDAT Kaupastillen against heartburn, 50 pcs

Detailed instructions for TALIDAT Kaupastillen against heartburn, 50 pcs

Field of use

• These chewing tablets are among the antacids. These are means of binding excess stomach acid. They are used for the symptomatic treatment of diseases in which the stomach acid is to be bound:
  • Gastric and duodenal ulcers (Ulcus ventriculi and ulcus duodeni)
  • Heartburn and acid -related stomach complaints

Active ingredients / ingredients / ingredients

500 mg hydrotalcit
Arab rubber auxiliary substance (+)
800 mg maltitol Hedge substance (+)
Maltodextrin auxiliary substance (+)
Sodium cyclamat auxiliary substance (+)
Paraffin, thin -fluid auxiliary material (+)
Saccharin, sodium salt auxiliary material (+)
Wax, bleached auxiliary material (+)
Xanthan rubber auxiliary substance (+)
0.067 Be total carbohydrates Hedge substance (+)

Contradictions

• The preparation must not be taken,
  • if you are allergic to hydrotalcit, menthol or one of the other components of this medicine;
  • if you suffer from severe kidney dysfunction.
• If your kidney function is restricted, you have an increased risk of increased enrichment of magnesium and aluminum in the blood with long -term use of high doses of this medicine. An increased enrichment of aluminum can lead to painful bone deviation (osteomalacia) or pathological, non -inflammatory brain changes (encephalopathy). Therefore, if the kidney function has been restricted, you may only use the medicinal product if the serum level of magnesium and aluminum is regularly checked by a doctor. An aluminum level of 40 µg/l should not be exceeded.
• If you are z. For example, due to a low -phosphate diet, there is a lack of phosphate (hypophosphatemia) or that it suffers from pathological muscle weakness or fatigue (Myasthenia gravis) should not take the preparation.

dosage

• Always take this medicine exactly as described or exactly after the agreement made with your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.
• Unless otherwise prescribed by the doctor, adults and children over the age of 12 take 1 - 2 chewing tablets (corresponding to 500 - 1000 mg hydrotalcit) several times a day between meals and before going to bed.
• The daily dose should not exceed 12 chewing tablets, corresponding to 6000 mg hydrotalcit.
• Other medicines should generally take place one to two hours before or after taking these chewing tablets.
• Application in children and adolescents
  • The drug should not be used to treat children under the age of 12, since there is no sufficient experiences in this age group.

• Duration of the application
  • The duration of the treatment depends on the type and severity and the course of the disease.
  • If the symptoms remain below the treatment for more than 2 weeks, a doctor should be consulted.
• Please speak to your doctor or pharmacist if you have the impression that the effect of the drug is too strong or too weak.

 

• If you have taken a larger amount than you should
  • Poisoning is unlikely due to the low absorption of aluminum and magnesium.
  • In the event of overdose, there may be changes in stool behavior such as stool deviation and increase in the frequency of stool. Therapeutic measures are generally not necessary here.

 

• If you have forgotten the intake
  • Do not take the double dose if you have forgotten the prior intake. Continue treatment with the prescribed dose.

 

• If you cancel the intake
  • Definitely speak to your doctor before you - e.g. B. due to the occurrence of side effects - interrupt the treatment or end it early.

 

• If you have any further questions about taking this medicine, ask your doctor or pharmacist.

Taking

• Taking it several times a day between meals and before going to bed
• Other medicines should generally take place one to two hours before or after taking the preparation.

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before taking the medicine.
    • If the function of your kidneys is restricted, you suffer from Alzheimer's or other forms of dementia or eat it with a phosphate, you should avoid long -lasting intake of high doses from this medicine.
    • Longer -lasting and recurring stomach complaints can be signs of a serious illness, such as: B. a stomach or duodenal ulcer. Treatment with this medicine should therefore not take longer than 14 days without a medical examination.
    • In patients with gastric or duodenal ulcer, an examination for the gastric bacterium H. pylori - and in the event of proof - a recognized antibacterial therapy should be considered, since the ulcer disease usually also heals when such therapy is successfully used.
    • If you occur of the taling, blood admixtures in the stool or vomiting of blood, please see a doctor immediately, as this can also be signs of a serious illness.
  • Children and adolescents
    • The drug should not be used to treat children under the age of 12, since there is no sufficient experiences in this age group.

 

• Wateriness and ability to operate machines
  • There are no special precautions required.

Pregnancy

• If you are pregnant or breastfeeding or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this drug.
• Reports on harmful effects of hydrotalcit during pregnancy and during the breastfeeding period have not become known. However, there are no specific studies on children whose mothers have taken hydrotalcit during pregnancy or lactation.
• Pregnancy
  • During pregnancy, the drug should only be taken after a medical consultation and at short notice to avoid aluminum pollution from the child. However, there is no risk for the newborn, since only very small amounts of the child are absorbed.
• Breastfeeding
  • In general, aluminum compounds pass into breast milk. However, there are no examinations for the transition of hydrotalcit to breast milk.

Hints

Otherit

- If the kidney function is restricted, there are chronic intake of high amounts of poisoning risks (magnesium surplus, increase in serum aluminum levels).
- With long -ending high amounts and low -phosphate diet, phosphate raving can occur with the risk of an osteomalzie. Therefore, in this case, long -lasting intake should be avoided.

- Part of the aluminum is absorbed and leads to an increase in the serum concentration of aluminum and an increase in aluminum excretion over the kidneys. Serum aluminum levels normalize in three to four days after stopping the treatment.

- A small part of the magnesium is recorded. The magnesium concentration in the serum usually remains the same by excretion over the kidneys.

- With limited kidney function and with long-term intake of high quantities, however, the gradual aluminum storage can primarily occur in the nerve and bone tissue as well as a magnesium surplus to magnesium poisoning, which is characterized by muscle weakness, reflex failures, paralysis, coma and through heartbeat disorders.
- Aluminum in the nerve tissue has a neurotoxic effect that has been proven in animal experiments.
- Aluminum deposits in the brain were detected in the dialysis relapse. Dialysis patients can lead to an aluminum -associated osteomalacia.
- Aluminum -associated anemia (microcytic, hypochrome anemia) was also described.

Therapy monitoring/control measures:
In the event of long -term use, aluminum blood level should be checked regularly and do not exceed 40 μg/l. This applies in particular to renal failure.

Manufacturer:  CHEPLAPHARM Arzneimittel GmbH, Bahnhofstrasse 1a, 17498 Mesekenhagen